Skip to search formSkip to main contentSkip to account menu

IRC 083927

Known as: IRC-083927, IRC083927 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Medicinal Chemistry - XXIst International Symposium.
  • Danny Chan
  • IDrugs : the investigational drugs journal
  • 2010
  • Corpus ID: 45115310
The XXIst International Symposium on Medicinal Chemistry from the European Federation of Medicinal Chemistry (EFMC-ISMC), held in… 
2009
2009
Abstract #5563: Superior in vivo antitumor activity of tubulin polymerization inhibitor IRC-083927 relative to anticancer drugs in a panel of human tumor xenografts
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO The synthetic small molecule IRC-083927 inhibits tubulin polymerization by a… 
2008
2008
IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents
Tubulin is a validated target for antitumor drugs. However, the effectiveness of these microtubule-interacting agents is limited… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)